Biomedical Research

Preventing Nerve Cell Deterioration After Traumatic Brain Injury

By Kyle Phong

Published 1:46 PM EST, Sat May 15, 2021


Traumatic brain injury (TBI) is often caused by a blow to the head and currently affects around five million people across the US. It is known to cause several neuropsychiatric conditions such as psychosis, mania, and Alzheimer’s disease, and can also lead to nerve cell deterioration. At the Harrington Discovery Institute in Cleveland, Ohio, Dr. Pieper and his team have discovered a way to prevent TBI-induced nerve cell deterioration in the brain.  They also found a possible explanation for the relationship between TBI and Alzheimer’s disease.

Osmosis, “Traumatic Brain Injury (TBI)” 


To explore the connection between Alzheimer’s and TBI, Dr. Pieper used previous knowledge of tau and acetylation in patients.  Tau is a protein in nerve cells that help guide nutrients throughout the neuron.  However, tau tangles with other tau molecules in patients with Alzheimer’s disease, resulting in weak synaptic communication between neurons and becoming acetylated-tau.  While experimenting with mice, Dr. Pieper found high levels of acetylated-tau (ac-tau) in different forms of TBI.  The elevated ac-tau persisted chronically if left without treatment.  Furthermore, patients with Alzheimer’s disease had even higher levels of ac-tau if they had a history of TBI.

Labiotech, “Healthy Neuron vs Alzheimer’s Disease Neuron”

Dr. Pieper’s team found two anti-inflammatory drugs (salsalate and diflunisal) that helped to protect the mice’s neurons from deteriorating after TBI.  These two medications inhibit the enzyme that causes tau acetylation, therefore preventing the transformation into ac-tau.  Upon this discovery, the researchers analyzed over seven million patient records regarding the usage of salsalate and diflunisal and realized that these medications were associated with a decrease in Alzheimer’s disease and TBI cases.  Additionally, they compared these two drugs with aspirin, a common anti-inflammatory drug, that does not prevent acetylation.  Dr. Pieper did not find any evidence of aspirin showing the same neuroprotective activity as salsalate and diflunisal.

Knowing that tau is a protein that diffuses from the brain into the bloodstream, the researchers wondered about ac-tau levels existing in the blood of TBI patients.  For both mice and humans, there was a significant increase of ac-tau in the blood.  However, these elevated levels returned to normal when treated with medications such as salsalate and diflunisal, showing again that they effectively protect nerve cells from deterioration. 


Dr. Rosa, the co-author of this study, explains that this newfound knowledge can have a variety of uses in the clinical setting.  The research team is continuing to examine ac-tau and its relationship with neurodegenerative diseases.  Additionally, they will study salsalate and diflunisal to see whether these drugs can be used as an established neuroprotective medication for humans. 

Kyle Phong, Youth Medical Journal 2021


News Medical Life Sciences, “Researchers discover a new way to prevent brain nerve cells from deteriorating after injury”, 13 April 2021

Cell, “Reducing acetylated tau is neuroprotective in brain injury”, 13 April 2021

Osmosis, “Traumatic brain injury: Clinical practice” Image

Labiotech, “How AC Immune CEO Andrea Pfiefer is Tackling Alzheimer’s Disease” Image, 1 August 2018

Health and Disease

A Multidimensional View on Sickle Cell Disease

By Kyle Phong

Published 7:14 PM EST, Sat April 17, 2021


Sickle cell disease (SCD), or sickle cell anemia, is a common health condition that affects about 20 million people worldwide.  Although this disease originates from mutations within our genes, there are several influences, such as psychological, environmental, and biological, that affect each person’s life expectancy and overall experience.  Recent research emphasizes the significance of understanding these influences in order to better treat SCD and all other hereditary diseases.

What is Sickle Cell Disease?

SCD is when red blood cells form a curved, crescent shape.  As shown in the diagram below, a healthy red blood cell is shaped like a disc.  Due to their deformed shape, these fragile sickle cells die quickly.  Red blood cells die faster than new ones can be created, resulting in a low red blood cell count.  Additionally, sickle cells often clog blood vessels because of their irregular shape.  This may completely block or slow the flow of blood and oxygen to various parts of the body.

Causes: SCD is a hereditary disease that is passed down from parents that both must have the sickle cell trait. Typically, having this trait is not harmful, but it can be passed onto children.  As shown in the graphic below, there is a 25% chance of having sickle cell disease if both parents have the sickle cell trait.

Symptoms: SCD can cause a variety of problems ranging from chronic pain to stroke.  Due to the fact that red blood cells play an important role throughout our body, symptoms of SCD can be seen anywhere.  Some early signs of SCD include jaundice, when our skin and eyes become yellow, as well as swelling in the hands and feet.

Treatments: Currently, a blood and bone marrow transfusion is the only known cure for SCD.  However, only specific individuals are able to receive this treatment.  These transplants are mainly done for children since they have the highest chance for success.  Additionally, a relative is needed to be a donor in order to be a good genetic match.

However, there are several medicines used today to treat SCD without curing it.  For example, Voxelotor is a newly approved medicine for ages 12 and up.  It improves blood flow by preventing red blood cells from forming a sickle shape.  


It was unsurprising for researchers to see that industrial countries with access to greater healthcare were able to extend the typical lifespan of someone with SCD.  There are seven domains of influence that all play large roles in our experience with SCD.  These domains include environmental, biological, sociocultural, structural, psychological, clinical, and behavioral.    

This Identity Networks, Genome, and Affect as Modulators of Health (INGAM) model displays a variety of SCD outcomes and factors ranging from drug addiction to anxiety.  There is often an emphasis on the biological and clinical domains of influence when dealing with SCD, but this disregards SCD’s multidimensional nature.  In order to properly treat SCD complications, one must take all factors into consideration.


International health organizations, such as the WHO, should encourage countries to implement more appropriate policies for SCD.  Some scientists believe that we are on the brink of discovering a molecular cure for SCD through the use of CRISPR.  However, it is unlikely for all countries to have immediate access to a newfound cure for SCD.  Therefore, it is crucial to develop new methods to reduce complications in the millions of people with SCD around the world.  Additionally, multifactorial diseases such as cystic fibrosis are greatly impacted both by genetic and environmental factors.  Rather than using a linear approach, we must consider that there are often many factors working in conjunction that result in SCD.  Using this multifaceted model, we can revolutionize the next steps in treating SCD as well as other complex diseases and ultimately improve the quality of life worldwide.

Kyle Phong, Youth Medical Journal 2021


Wiley Online Library, “Sickle cell disease is a global prototype for integrative research and healthcare,” 25 February 2021

News Medical Life Sciences, “A single letter difference in a single gene spells a lifetime of anemia, pain worldwide,” 2 March 2021

Center for Disease Control and Prevention, “What is Sickle Cell Disease?”

Medline, “Sickle cell disease”

National Heart, Lung, and Blood Institute, “Sickle Cell Disease”

Biomedical Research

Changing Our Understanding of Medulloblastoma

By Kyle Phong

Published 11:16 PM EST, Mon March 1, 2021


At St. Jude Children’s Research Hospital, scientists conducted the largest analysis of primary and relapsed medulloblastoma tumors to date. The research team divided medulloblastoma into four molecular groups: WNT, SHH, (both named after their genetic mutation), Group 3, and Group 4.  Upon discovering that about one-third of these patients relapsed and displayed a five-year survival rate of 10%, the researchers sought to find out why this was occurring.

What is Medulloblastoma?

Currently, medulloblastoma is the most commonly found brain tumor in children younger than 16 years old.  If it is not detected early and treated, it tends to spread to other areas of the brain as well as the spinal cord. The specific cause of medulloblastoma is not known, but cancer is formed due to the uncontrolled, rapid division of a mutated cell. A small percentage of childhood medulloblastomas are hereditary.  

Symptoms: Typical symptoms for a child with medulloblastoma are worsening nausea and vomiting, clumsiness, headaches, and seizures.  If cancer has metastasized to the spinal cord, the child might also experience problems walking, back pain, and difficulties with controlling their excretory functions.  

Survival Rate: Assuming the tumor has not spread, the survival rate is 70-80%, which is fairly high compared to several other cancers. If it has spread to the spinal cord, the rate lowers to about 60%.  

Treatment: The three main treatments of medulloblastoma are surgery, radiation, and chemotherapy. During surgery, as much of the tumor is removed as possible without jeopardizing the patient’s health.  Depending on how much of the tumor is left, the patient then undergoes radiation therapy and chemotherapy. Radiation therapy is when high radiation such as X-rays kills cancer cells. Chemotherapy is a medicine that is injected or orally consumed to kill cancer cells. 

Research and Data Analysis 

In the study, each of the four groups of medulloblastoma was then organized by their five-year survival rate. WNT tumors have a 95% five-year survival rate, SHH and Group 4 have about a 75% five-year survival rate, and Group 3 has a 60% five-year survival rate. Next, the research team analyzed data from two trials, SJMB03 and SJYC07. SJMB03 includes international children with newly diagnosed medulloblastoma from 2003-2012.  SJYC07 includes children younger than 3 years old with newly diagnosed medulloblastoma. They found that approximately one-third of patients either experience treatment failure or relapse, which is when cancer returns, and only 10% survive past five years post relapse.  

Further analysis of results revealed that about 10% of these relapsed medulloblastomas were wrongly classified. These were actually secondary malignancy which is cancer caused by radiation or chemotherapy. These secondary cancers manifest as high-grade gliomas, which are aggressive and incurable. High-grade gliomas and relapsed medulloblastoma have different treatments, therefore patients who were misclassified received incorrect medicine.  

Researchers found that medulloblastomas typically stay in the same molecular group when relapsed, but there has been evidence of some switching from Group 3 tumors to Group 4.  Despite this evidence, the research team learned that most of the time, tumors are genetically stable. Using whole-exome sequencing, they found patterns of relapse in childhood medulloblastoma.


Dr. Robinson, an oncologist at St. Jude, states that this research provided a better understanding of medulloblastoma and its risks. Depending on the type of medulloblastoma, we are able to determine a more precise amount of, along with the specific type of therapy needed for the patient. Now able to better understand these tumors, treatment of relapsed medulloblastoma may significantly improve. 

Kyle Phong, Youth Medical Journal 2021


Journal of Clinical Oncology, “Clinical Outcomes and Patient-Matched Molecular Composition of Relapse Medulloblastoma”, 27 January 2021

News Medical Life Sciences, “New results challenge the current understanding of medulloblastoma”, 28 January 2021

St. Jude Children’s Research Hospital, “Medulloblastoma”

Together Powered by St. Jude Children’s Research Hospital, “Medulloblastoma in Children and Teens”

National Cancer Institute Center for Cancer Research, “Medulloblastoma Diagnosis and Treatment”

Biomedical Research

A New Stroke Risk Factor for Elders


Geisinger is a health organization that offers healthcare services in Pennsylvania and New Jersey.  A team of Geisinger researchers discovered a new risk factor for stroke that was more common in people ages 65 and up.  Dr. Abedi, a co-author of the study and genomics scientist at Geisinger, states, “Stroke is a complex multifactorial condition.”  Out of the main causes for stroke, cerebral small vessel disease is among the most common reasons.

Cerebral Small Vessel Disease

Cerebral Small Vessel Disease, abbreviated as SVD, is a general term for problems related to small blood vessels in the brain.  It is a common disease that is known to cause vascular dementia and around a quarter of ischemic strokes.  About 87% of all strokes are ischemic, meaning that the blood supply to the brain is blocked off, causing brain cells to die.  While we typically notice SVD with old age and hypertension, some of the cases are due to variants in the NOTCH3 gene.  This gene variant is quite common, about 1 in 300 people worldwide.  Additionally, CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a rare hereditary condition, is associated with a higher risk of stroke and SVD.  CADASIL is known to cause a variety of health issues, ranging from seizures to cognitive deterioration. 


The Geisinger team studied the health records of over 300 of their patients.  Out of these patients, 118 of them were found to have the NOTCH3 gene variant.  The researchers sought to find out if those with the NOTCH3 variant had more severe SVD as well as a higher risk of stroke and brain damage.  They created a control group, consisting of patients without the NOTCH3 variant, and an experimental group, consisting of patients carrying the NOTCH3 gene variant.  4.9% of the control group had a history of stroke compared to 12.6% of the experimental group.  The significant increase in the risk of stroke is likely due to the NOTCH3 gene variant.  Meanwhile, the specific NOTCH3 variant that causes CADASIL was rarely found.  In addition, patients over the age of 65 were noted as more prone to stroke and exhibited more damage to the brain.  

This diagram displays the risk of getting a stroke as we become older through the red experimental group and green control group.  From ages 0 to around 70, we notice that both groups are relatively the same percent free of stroke.  However, there is a sharp decline in percentage free of stroke after the age of 70 for those carrying the NOTCH3 gene variant.  The table below shows the N at risk, meaning the number of individuals at risk of stroke, and N stroke, which is the number of people with their first stroke in 10-year intervals.  This shorter stroke-free survival compared to the control group reinforces the idea that the NOTCH3 gene is a significant contributor to stroke risk.  


Due to the high number of individuals carrying the NOTCH3 variant, there is a significant risk of SVD and stroke.  Additionally, the Geisinger research team has claimed that most people with the NOTCH3 variant will have SVD after the age of 65.  With this new knowledge, we can continue to advance the field of medicine and prevent the strokes of individuals carrying the NOTCH3 gene variant, saving the lives of many.

Kyle Phong, Youth Medical Journal 2021


Stroke Association, “Types of Stroke”

Stroke: Journal of the American Heart Association, “Top-NOTCH3 Variants in the Population at Large”, 9 November 2020

Stroke: PubMed, “Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population”, 9 November 2020

News Medical Life Sciences, “A common genetic variant identified as risk factor for stroke”, 19 January 2021

National Institute of Neurological Disorders and Stroke, “CADASIL Information Page”, 27 March 2019 Page#:~:text=CADASIL%20is%20characterized%20by%20migraine,higher%20risk%20of%20heart%20attack.

Biomedical Research

The Key Gene in Destroying Viruses


The University of Texas Southwestern Medical Center has found a crucial gene that is involved in our body’s natural process of destroying viruses. Manipulating this gene can lead to the creation of many treatments for a wide range of viral infections, even COVID-19. Ph.D., Xiaonan Dong, and his team began with observing human cells infected by a variety of viruses and examining over 18,000 genes in order to find the effect they may have on autophagy. 

What is Autophagy?

Autophagy is our cells’ process of recycling damaged parts by breaking them down and using them as “building blocks” to create new components. However, it degrades more than just defective cells. Autophagy is also known to destroy bacteria and viruses that can cause infection.    

In this diagram, the unwanted material, such as dysfunctional organelles, is isolated into the autophagosome. Then, the autophagosome is fused with single-layered vesicles called lysosomes which degrade and recycle the cellular garbage.


First, the team began with herpes simplex virus type 1 or HSV-1 and Sindbis virus.  HSV-1 is a common and contagious virus known for causing sexually transmitted diseases as well as cold sores. Meanwhile, the mosquito-transmitted Sindbis virus causes rash, headache, and joint pain. From these two viruses, researchers found 216 genes that played a role in viral autophagy. In order to reveal the genes that had the most influence on autophagy, they analyzed the processes that these genes regulated through a method of bioinformatics. Bioinformatics is a method of studying biological data such as DNA and amino acid sequences with the assistance of computer science.  

Soon after, Dong and his colleagues discovered a gene named sorting nexin 5 or SNX5 which performed a recycling action similar to autophagy. Viruses typically enter cells through this specific pathway, so researchers made the hypothesis that SNX5 is a key player in autophagy. In order to confirm this, they deactivated SNX5 in their experiment with the human cells. Consequently, the cells were much more inefficient when performing autophagy on HSV-1 and Sindbis viruses. Meanwhile, autophagy to recycle dysfunctional cells and remove bacteria was activated, showing the same results as the control group. This suggested that SNX5 was a gene that specifically aided viral autophagy.


The research team experimented with many other viruses such as influenza A, West Nile, and poliovirus. In all of these trials, the results had suggested that SNX5 was a crucial component in our body’s defense mechanism against viruses.  Furthermore, canceling SNX5 showed an increase in susceptibility to viral infection for both human cells and animal cells.

With Dong’s identification of SNX5 is a crucial gene in viral autophagy, scientists can potentially manipulate SNX5 and find new methods of fighting off viruses. Today, we treat viruses by studying their individual weaknesses, meaning that every virus requires a different approach. Dr. Dong explains that by better understanding the way our body naturally degrades viruses, we can create a “more general strategy for developing broad-spectrum antiviral therapeutics that combat an array of different viral infections.”  With our newfound knowledge of SNX5 in viral autophagy, we can take the next step in medicine by improving our immune systems. 

Kyle Phong, Youth Medical Journal 2021


Nature, “Sorting nexin 5 mediates virus-induced autophagy and immunity, 16 December 2020,

News Medical Life Sciences, “Researchers identify key gene necessary for cells to consume and destroy viruses”, 17 December 2020,

UT Southwestern Medical Center, “Giving cells an appetite for viruses”, 16 December 2020

National Cancer Institute, “Autophagy”

National Human Genome Research Institute, “Bioinformatics”,DNA%20and%20amino%20acid%20sequences.

Biomedical Research

Tai Chi: The Martial Art of Healing


As we enter our later stages of life, it becomes even more crucial that we take good care of our bodies, whether it is maintaining a healthy diet or getting enough exercise every day.  However, there are many additional activities that can be done such as tai chi, which have a multitude of benefits, ranging from reducing the risk of falling to alleviating pain.  Tai chi is a Chinese martial art that emphasizes slow, flowing movements, meaning almost anyone is capable of doing it.

While growing older, we may notice that our muscles and bones become weaker, our reaction time is slower, and our focus is not as sharp as it used to be.  Tai chi is a simple and non-invasive method that has been shown to counter all of these issues.  Ph.D. Peter Wayne, an associate professor at Harvard Medical School and director of the Osher Center for Integrative Medicine, explains that adults over the age of 65 can see a 20% – 40% reduction in the risk of falls, even after a short six months of practicing tai chi.


A 2012 research paper by Cochrane, a British organization dedicated to cover medical research findings, found that about 30% of people over 65 years fall each year.  They pooled data from about 160 trials and over 79,000 participants, looking for methods that were the most effective in preventing seniors from falling.  One example of a method consisted of several groups and home-based programs working on strength and balance exercises.  In general, they found that any seniors that actively did exercises were less prone to falls and sustaining severe injuries.  

In addition, there is strong evidence that tai chi assists in strengthening our bones.  As we age, it is common for us to have osteopenia which is when our bones become brittle due to a lack of calcium.  Our body becomes unable to make new bone cells as fast as it reabsorbs old bone cells.  However, tai chi has been shown to stimulate bone growth which combats the effects of osteopenia.  

One research paper from the National Center for Biotechnology Information (NCBI) studied the health effects of tai chi on people with certain bone conditions such as knee osteoarthritis and bone mineral density loss.  This study recognized prior research that contained strong evidence for the beneficial effects of tai chi and sought to make a definitive claim.  

Like the paper from Cochrane, NCBI noted that tai chi does mitigate the effects of bone mineral density loss.  This research was a 24 week long program consisting of a diverse population from breast cancer survivors to diabetic older adults.  The constant use of the waist and slow full body movements were the two main features that attributed to slowing bone mineral density loss.  In addition, NCBI found that tai chi also helped with flexibility, increasing muscular strength, controlled breathing, regulating blood pressure, and balance.  This is especially beneficial to older adults with hypertension or high blood pressure and Parkinson’s disease which is known to cause loss of balance, stiffness, tremors and slow movement.  There was an in-depth look into specific forms of tai chi such as the Sun-style, composed of quick movements, and Yang-style which is the most common form associated with slow, stretching movements.  However, among the three tai chi forms, they all shared benefits, specifically relating to bone health.


Tai chi involves a variety of movements and emphasizes control over the body from breathing to balance.  It contains several exercises that require shifting weight and maintaining balance which is vital for many seniors.  Regardless of what style of tai chi is practiced, it has proven to be very beneficial.  From personal experience, some of my relatives have been practicing tai chi for decades and it has helped their physical and mental health tremendously.  Tai chi is a low impact form of exercise that people of any age are capable of performing.  From reducing the risk of falls to alleviating chronic pain such as knee osteoarthritis, tai chi has a variety of positive impacts on our health.

Kyle Phong, Youth Medical Journal 2020


Harvard Health Publishing, “Protect your bones with tai chi”, October 2020,

Cochrane Library, “Interventions for preventing falls in older people living in the community”, 12 September 2020,

Harvard Magazine, “Easing Ills through Tai Chi”, February 2010,

Medical News Today, “What are the health benefits of tai chi?”, 30 August 2018,

NCBI, “The Effect of Taichi Practice on Attenuating Bone Mineral Density Loss: A Systematic Review and Meta-Analusis of Randomized Controlled Trials”, 1 September 2017, 

Tai Chi Image 

Health and Disease

Defeating Breast Cancer While Leaving Healthy Cells Unaffected


Cancer treatment today often includes a painful experience for the patient.  Chemotherapy is known to contain powerful substances that kill rapidly dividing cells, even healthy ones.  Scientists at Johns Hopkins Medicine and the University of Oxford recently published their results with a new technique they’ve been working on that is capable of killing breast cancer cells while keeping healthy cells safe.  One common cause of cancer is a mutation within the genetic coding of a cell that causes it to multiply without anything to suppress it.  This unrestricted division of the cell can lead to them becoming cancerous. 

How does cancer start? Damaged cells multiply.


While studying lab-grown breast cancer cells, one of the lead researchers, Dr. Holland, noticed a trend amongst them.  The cancer cells were dependent on centrioles, which played a crucial role in their survival and multiplication.  Centrioles are cylindrical organelles that form necessary spindles in mitosis, a process in which cells divide.  They are the core of centrosomes that provide structure for cells and assist in separating DNA during cell division.  Although other cells were able to divide without centrioles, these breast cancer cells were not able to.  With deeper research, they found that there was a section of the cancer cells that had multiplied a strange amount of times.  One specific protein, TRIM37, was being produced excessively by genes in that area.  This protein controls centrosomes and when there are high levels of the protein, it results in defective centrosomes instead.  These flaws lead to consequences later during cell division and this instability in cell division typically contributes to the development of cancer.

In order to impede the division of cells with an excessive amount of TRIM37, researchers utilized a drug that targeted PLK4 genes.  The PLK4 inhibitor specifically hinders the proteins that form centrioles.  Unfortunately, they found that adding this drug to their lab-grown breast cancer cells with normal levels of TRIM37 does not impact their cell division even without centrioles.  However, for the cells with overexpressed TRIM37, they were unable to divide and died or did not grow anymore.  Holland devised a plan to identify cells that contained high levels of TRIM37 and allow the PLK4 inhibitor to kill the breast cancer cells without harming the healthy cells.

They came across precisely why the cancer cells with regular levels of TRIM37 were unaffected by the PLK4 drug.  Diagram D shows the effects of the PLK4 inhibitor on a cancer cell with regular levels of TRIM37 compared to a cancer cell with an excessive amount of it.  There is a substance called the pericentriolar material (PCM) around the centrioles that performs the same function as centrosomes.  In the first path, it states that the “PCM foci promote MT nucleation” which means that the pericentriolar material substitutes for the depleted centrosomes in order for cell division.  On the other hand, the cells overexpressing TRIM37 eventually died.  The high levels of TRIM37 deteriorates the pericentriolar material and the PLK4 drug stops the production of centrosomes.  Without these two, there is no way for the cell division to occur.  


 This research from Johns Hopkins Medicine and the University of Oxford is a breakthrough in the world of cancer.  9% of breast cancers are caused by the over-expression of TRIM37 and being able to kill these cancer cells while leaving the healthy ones unaffected is a huge step towards finding the best way to treat cancer.  Holland and the team are now working on using similar drugs to the PLK4 inhibitor because it is not stable and safe enough to use for patients.  In addition, they are testing this inhibitor on other cancer cells to see if they are sensitive as well.  Dr. Chapman, another researcher on the team, stated, “We’ve found a previously unknown genetic vulnerability in breast cancer, and discovered a means to exploit this vulnerability and selectively kill cancer cells.  We hope that in the future, other researchers and pharmaceutical companies can generate new drugs that can target this process, to produce more effective and safer cancer treatments.”


Nature, “Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer”, 9 September 2020,

Johns Hopkins Medicine. “New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed.” ScienceDaily. ScienceDaily, 9 September 2020.

University of Oxford, “Previously unknown ‘genetic vulnerability’ in breast cancer cells target of research.” 10 September 2020

Johns Hopkins Medicine, “Scientists Identify New Way to Target Some Rapidly Dividing Cancer Cells, Leaving Healthy Cells Unharmed”, 9 September 2020

Fierce Biotech, “Blocking tumor cell division to stop breast cancer.” 9 September 2020,

National Human Genome Research Institute, “Centriole”,

Sciencing, “What Would Happen If a Cell Didn’t Have Ribosomes?”, 16 April 2018,

Patient Navigator Training Collaborative,


The Inferior Temporal Cortex “Recycled” to Aid Reading


One of the many strengths of humans is the ability to create and understand intricate languages of reading and writing. Scientists have long debated how humans’ brains have developed these reading and writing specific skills in such a short time.  Neuroscientists’ recent study from Massachusetts Institute of Technology, however, has unveiled that rather than our brains evolving to perform linguistic functions, the inferior temporal cortex (IT cortex) has been “recycled”.  In functional magnetic resonance imaging (fMRI) research, a region within the IT cortex known as the visual word form area (VWFA) lightens when the brain recognizes orthographic stimuli, in this case, words.  Additionally, researchers used fMRI to find that areas of the IT cortex meant for face and object recognition lit up distinguishing words after learning to read. This shows that the human mind is adaptable and can repurpose itself for different tasks, and in this case, for reading.


To test this theory, Old-World monkeys, such as baboons and rhesus macaques, which diverged from humans about 25 million years ago, were studied.  Despite not being perfect models for the human mind, these primates have enough similarities to be comparable.  Research has shown that we share similar functions and structures in the ventral visual pathway which is a section of the brain utilized for object recognition. In prior research from 2012, baboons were able to differentiate real English words and nonsensical combinations of letters or non-words with enough training.  This proves that word recognition is something that does not require years of evolution and a complex understanding of linguistics.  However, researchers still pondered the neural workings behind this skill.  

This curiosity led to a new test, where scientists used microelectrode arrays to record the neural activity in untrained macaque monkeys while they examined both words and non-words.  These arrays were placed in the monkeys’ IT cortex as well as a part of their visual cortex called V4, which connects to the IT cortex.  Then, they put the data into a linear classifier, a computer model designed to identify whether or not words triggered neural activity in the monkeys.  Dr. Rishi Rajalingham, the lead of this study, explained that this process is very effective and easy, because there is no training necessary for the monkeys.  


In this diagram, Model A presents an example of text the macaque monkeys would view, a visual of the IT cortex, and V4 lighting up.  On the right, the figure shows which orthographic tests affect which specific neurons using data from the microelectrode arrays.

Model B displays three different sets for the monkeys.  The first contains samples of words and random assortments of letters, and the second tests the variation in the size and spacing of the words. The third set displays one letter but each card has the letter in different locations.  

Model C presents the location of the microelectrode arrays in 4 example monkeys: N, S, B, and M.  To the right are 8 different graphs representing example IT sites, each with some of the monkeys’ neuronal response to a set of 5, consisting of both words and a random string of letters.  The colors of the data show the intensity of the response with blue being the lowest and red being the highest.  In addition, there is shading around some sections of the data that represents the general margin of error.  Over the 300 millisecond time frame, many of the words sparked higher responses in the monkeys compared to the jumbled letters despite having no prior training or experience with orthographic stimuli.  

The model displayed that the data corresponding to the IT cortex was about 70% accurate, with both performance and errors made by these monkeys similar to the baboon study in 2012.  Meanwhile, the visual cortex was notably less accurate which reveals that the skilled areas of the IT cortex for object recognition are specifically capable of being remodeled if needed for reading.  These observations reveal that the IT cortex in untrained monkeys is sufficient enough to complete simple orthographic tasks such as word recognition.  In the future, researchers plan on studying both trained monkeys and literate humans to compare results. With adequate training, our brains are capable of learning to read without highly evolved brains and by “recycling” our IT cortex.


The inferior temporal cortex is a potential cortical precursor of orthographic processing in untrained monkeys, Nature Communications, August 2020

“Parts of the human brain have been ‘recycled’ for reading, indicates study”, News Medical Life Sciences, August 2020

“To read, humans ‘recycled’ a brain region meant for recognizing objects”, United Press International, August 2020

“Key brain region was ‘recycled’ as humans developed the ability to read.”, MIT News, August 2020

Orthographic Processing in Baboons (Papio papio), Science, April 2012

Kyle Phong, Youth Medical Journal 2020

Health and Disease

How Pesticides Increase the Transmission Rate of Schistosomiasis 

Both pesticides and fertilizers have had their dark history of harming the environment, yet it is still commonplace today.  The continuous usage of agrochemicals carries far more unintended consequences than we expected.  Recent discoveries from the University of California, Berkeley research team has revealed that the rising water developmental projects such as dams have allowed a rise in the freshwater snail population, while dispersing its predators which are necessary for keeping its numbers in check.  In addition, agrochemicals we utilize today are polluting the environment, therefore increasing our exposure and vulnerability to infectious diseases, particularly schistosomiasis.  

What is Schistosomiasis?

Schistosomiasis, known as bilharzia or snail fever, derives from parasitic worms (In this case, Schistosoma haematobium) in tropical and subtropical freshwater environments.  This disease earned the moniker “snail fever” due to the schistosome parasites’ use of snails as their hosts.  As a result, the freshwater becomes contaminated, when humans make contact with these waters parasites burrow into their bodies.  The worms travel through the bloodstream to vital organs such as the liver, kidney, and intestines.  Meanwhile, females lay their eggs which are passed through human urine and feces.  If these excretions reach freshwater sources, they will repeat the process to inhabit snails and grow before infecting another human. Without this trend, the parasitic eggs remain in the body and are attacked by the immune system.  There are different symptoms as they pertain to the infected area.  For example, one might experience seizures, headaches, and loss of balance if their nervous system is infected.  If not treated properly, short-term or acute schistosomiasis can lead to long-term or chronic schistosomiasis.  In this state, females will continue to reproduce and infected organs can be critically damaged.  


Researchers have found that the utilization of agrochemicals has accelerated the transmission process of schistosomiasis.  Some effects of agrochemical pollution include eliminating snail predators, increasing algae which are a main food source for the snails, as well as impacting the schistosome parasites’ survival directly.  The insecticides, chlorpyrifos, and profenofos are toxic to the predators that hunt these snails which allows the freshwater snail population to increase dramatically, activating a top-down trophic cascade.  Atrazine, an agricultural herbicide, was discovered to indirectly aid the growth of the algae which these snails consume, causing a bottom-up trophic cascade.  The snail population expanded, allowing more snails to serve as intermediate hosts for the parasites. Sub-Saharan Africa, where over 90% of schistosomiasis cases originate, has been exponentially increasing its application of agrochemicals in hopes for efficient and less arduous methods of farming.  With an ever-increasing freshwater snail population, the waterborne parasite population grows as well, resulting in a rise in the human infection rate.

This diagram from The Lancet Planetary Health shows the use of different agrochemicals and their effects in relation to the study.

In addition, researchers input their data into a complex mathematical model in order to have a general form of structure for the situation.  Then, they could easily approximate the R0 (basic reproduction number) of the schistosomes.  The R0 of S haematobium was about 1.65 while in an agrochemical-free environment.  However, the R0 has increased triple the amount when affected by agrochemicals.  The model was also capable of estimating the number of DALYs (disability-adjusted life-years) lost per 100,000 people from the altered schistosomiasis.  This represents about how many years are lost due to the disease they have.  It has been approximated that there have been 142 additional DALYs lost per 100,000 people.  By discovering the effects of individual chemicals within the pesticides, the research team could estimate both the R0 and DALYs that each caused.


This isn’t the first time we’ve witnessed the ramifications of using agrochemicals.  One notable instance was the widespread usage of the insecticide, DDT, which leaked into waterways, poisoning fish and other aquatic life.  When bald eagles consumed these toxic fish, they lost the ability to produce sturdy eggshells for their offspring.  As a result, the eggs often did not survive due to its lackluster protection which led to a massive decline in the bald eagle population.  

There are countless chemical compounds used in pesticides, all harboring dangerous side effects that can greatly impact the ecosystem.  Justin Remais, a leading figure in UC Berkeley’s School of Public Health, explains that reducing agrochemical pollution will not only reduce risk of schistosomiasis, but other infectious diseases as well.  Now that we know agrochemicals cause both unwanted direct and indirect effects, it is especially crucial that we find alternative methods to lower the risk of transmission by eliminating agrochemical pollution in regions where schistosomiasis is endemic.  


  • Effects of agrochemical pollution on schistosomiasis transmission: a systematic review and modelling analysis,The Lancet Planetary Health, July 2020

  • “Schistosomiasis”, World Health Organization, March 2020,where%20the%20females%20release%20eggs.

  • “Pesticide use can speed the transmission of schistosomiasis”, News Medical Life Sciences, July 2020

  • “Schistosomiasis (bilharzia)”, National Health Service, November 2018